The university licenses its original patent to the company to develop the product and conduct early-stage clinical trials.
Image: Michael Keidar, a mechanical engineer by training, is a professor of engineering at George Washington University. WILLIAM ATKINS
{iframe}https://www.bizjournals.com/washington/news/2020/12/08/gwu-md-biotech-targeting-cancer-and-covid.html{/iframe}